Several Prostate Cancer Drug Candidates Heading Into Home Stretch
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
In the next year or so, the race to develop new drug therapies for aggressive end-stage prostate cancer could heat up considerably, with several late-stage therapies due to report data in 2009 and early 2010.